摘要
国际骨髓瘤学会(IMS)年会是国际骨髓瘤领域顶级学术交流会,会议报道内容体现骨髓瘤最前沿的基础和临床研究进展。2023年第20届IMS年会报道了骨髓瘤微环境改变、免疫治疗以及新治疗靶点的发掘等方面的最新研究进展,促进了多发性骨髓瘤及浆细胞疾病的学科交流。
The International Myeloma Society(IMS)Annual Meeting is the top international academic meeting of myeloma,and the content of the meeting reflects the latest basic and clinical research progress in myeloma.The 20th IMS Annual Meeting in 2023 reported the latest progress of myeloma microenvironment change,immunotherapy and the discovery of new therapeutic targets,which promote the disciplinary communication in multiple myeloma and plasma cell disorders.
作者
孙洗月
郝牧
Sun Xiyue;Hao Mu(State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Hematology&Blood Diseases Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Tianjin 300020,China)
出处
《白血病．淋巴瘤》
CAS
2024年第4期199-202,共4页
Journal of Leukemia & Lymphoma
基金
国家自然科学基金(82170194,82370210)。
关键词
多发性骨髓瘤
免疫疗法
免疫微环境
国际骨髓瘤学会
Multiple myeloma
Immunotherapy
Immunomicroenvironment
International society of myeloma
